Combining the pan‐aurora kinase inhibitor <scp>AMG</scp> 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
Channing J. Paller(Johns Hopkins University), Sushant K. Kachhap(Johns Hopkins University)
Cited by 30
Related Papers
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
|The Oncologist|2013|178
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
|Cancer Research|2012|113
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
|Oncotarget|2014|63
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
|Cancer Chemotherapy and Pharmacology|2016|31